Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, has announced that CEO Jon Greenwald will present at the fourth annual Life Science Intelligence (LSI) USA ’23 Emerging Medtech Summit on March 22, 2023, at 11:30 a.m. PT (Track 1) in Dana Point, California.

The presentation will highlight Caira’s mission to make advanced orthopedic technologies more accessible to surgeons, patients, ambulatory surgery centers (ASCs), and hospitals around the world by removing the adoption barriers inherent to existing technology, with the intention of disrupting the $13 billion joint replacement market with Caira’s superior, proprietary technology. The business will also unveil its first product, the Caira Radar Navigation System for Total Knee Replacement, to investors and key partners (TKR). TKR is the segment with the highest percentage of patient dissatisfaction and the greatest revision load. It is also the segment with the highest volume of procedures.

The Caira TKA Radar Navigation System is the first sub-millimeter accurate radar tracking system for orthopedic surgery and offers considerable enhancements over the high-priced, large-footprint, and invasive surgical gear provided by existing surgical navigation and robotic systems. Utilizing sophisticated radar surgical tracking and rapid landmark registration, the Caira system fits smoothly into the surgeon’s workflow, enhancing accuracy, efficiency, and repeatability while simultaneously reducing cost, complexity, and a number of dangers associated with outdated technology.

“Orthopedic surgeons need advanced technologies that are aligned with the cost, efficiency, and patient outcome requirements of the rapidly expanding global joint replacement market,” said Morteza Meftah, M.D., Caira Co-Founder and Associate Professor of Orthopaedic Surgery at New York University Langone Medical Center and President of the International Society for Technology in Arthroplasty. “I think that the Caira TKA Radar Navigation System will radically redefine the paradigm of navigation and robotics in arthroplasty – offering surgeons, hospitals, and ASCs throughout the world with a better choice while also increasing patient results.”

By delivering a minimally invasive and cost-effective solution, Caira Surgical’s technology is a significant advancement that assists in overcoming the constraints that have impeded the widespread market acceptance of existing robotic and navigation systems. Due to their inherent disadvantages, such as expensive capital equipment and per-surgery disposables, complex workflows and increased procedure times, additional incisions and invasive surgical hardware that can increase post-operative pain and complications, these advanced technologies are currently utilized in less than 20% of TKA procedures.

Jon Greenwald, chief executive officer of Caira Surgical, remarked that the Caira TKA Radar Navigation System tackles each of these flaws to transform orthopedic surgery. With the introduction of surgical navigation and robotic technology in the 1990s, surgeons, hospitals, and ambulatory surgery centers have expressed discontent with workflow, complexity, invasiveness, and expense.

Currently, Caira Surgical is soliciting $10 million for their Series A Fundraising Round. The Series A money will be utilized to support further product development and research and development, as well as the 2024 limited commercial release of the Caira TKA Radar Navigation System. Anyone interested in booking a one-on-one meeting with Caira Surgical’s senior leadership at the Emerging Medtech Conference can do so by emailing the company.

    Leave a Reply